Carlos Herrera

Specific keynote: molecular determinants of angiogenesis in ovarian cancer.

J. Wood, I. Fidler, Lei Xu, 2003, Gynecologic oncology.

Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases.

J. Wood, I. Fidler, J. Yoneda, 2000, International journal of oncology.